As a matter of fact, PTX3 was found to be elevated in SSc patients with DUs or PAH, and a multivariate analysis identified elevated levels of this protein not only as an independent parameter associated with the presence of DUs and PAH but also as a useful predictor of future occurrences of DUs [90]. This evidence concerns the gene PTX3 and systemic sclerosis.